Thomas A. Russo, MD, SUNY Distinguished Professor and chief of infectious diseases at the Jacobs School, is co-author on a Nature Communications paper analyzing hypervirulent pneumoniae infections.
The FDA has approved GSK’s gepotidacin, the first antibiotic for uncomplicated urinary tract infections in 30 years. The drug has been approved for female adults and adolescents with UTIs caused by ...
The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...
Mexican company Henkel Capital S.A. de C.V. recalled its contaminated Tec Italy shampoo that was distributed in New York and ...
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
The O-specific polysaccharide of Klebsiella pneumoniae in patients with bloodstream infections is immunogenic, and its closely related subtypes are cross-reactive.
The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...
Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback